POU3F4
POU domain, class 3, transcription factor 4
Also known as: PO3F4_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- P49335
- Gene
- POU3F4
- Canonical length
- 361 aa
- Protein class
- Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for POU3F4 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
361 residues, UniProt reviewed canonical sequence.
>P49335|POU3F4
1 MATAASNPYS ILSSTSLVHA DSAGMQQGSP FRNPQKLLQS DYLQGVPSNG HPLGHHWVTS
61 LSDGGPWSST LATSPLDQQD VKPGREDLQL GAIIHHRSPH VAHHSPHTNH PNAWGASPAP
121 NPSITSSGQP LNVYSQPGFT VSGMLEHGGL TPPPAAASAQ SLHPVLREPP DHGELGSHHC
181 QDHSDEETPT SDELEQFAKQ FKQRRIKLGF TQADVGLALG TLYGNVFSQT TICRFEGLQL
241 SFKNMCKLKP LLNKWLEEAD SSTGSPTSID KIAAQGRKRK KRTSIEVSVK GVLETHFLKC
301 PKPAAQEISS LADSLQLEKE VVRVWFCNRR QKEKRMTPPG DQQPHEVYSH TVKTDTSCHD
361 LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against POU3F4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 20 nTPM
- cerebral cortex: 4.2 nTPM
- midbrain: 2.8 nTPM
- amygdala: 2.2 nTPM
- hypothalamus: 2.1 nTPM
- cerebellum: 1.5 nTPM
Single-cell type
- bergmann glia: 22 nCPM
- brain inhibitory neurons: 15 nCPM
- renal collecting duct principal cells: 13 nCPM
- ependymal cells: 9.3 nCPM
- astrocytes: 7.8 nCPM
- oligodendrocyte progenitor cells: 6.7 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 24 nTPM
- midbrain: 12 nTPM
- thalamus: 6.5 nTPM
- medulla oblongata: 5.7 nTPM
- cerebellum: 4.9 nTPM
- spinal cord: 4.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about POU3F4.
Disease | AllUniProt
Conditions POU3F4 is implicated in, by any mechanism.
- Deafness, X-linked, 2 (DFNX2) MIM:304400
Disease | GeneticClinVar
109 pathogenic / likely-pathogenic of 220 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- X-linked mixed hearing loss with perilymphatic gusher
- Rare genetic deafness
- Nonsyndromic genetic hearing loss
- Autosomal recessive sensorineural hearing loss
- Ear malformation
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0.57
- gnomAD missense Z
- 1.93
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- brain development
- cochlea morphogenesis
- negative regulation of mesenchymal cell apoptotic process
- regulation of transcription by RNA polymerase II
- sensory perception of sound
Molecular functions
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of POU3F4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POU3F4 as an antibody target. Whether an autoantibody or antibody against POU3F4 could matter depends on whether native POU3F4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POU3F4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label POU3F4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...